Encompass Health is trading higher as the market revisits the company’s most recent earnings update and forward outlook, with optimism centered on its 2026 guidance framework and continued demand for inpatient rehabilitation services. The latest company-issued outlook calls for full-year 2026 EPS of $5.81 to $6.10 and revenue of $6.37 billion to $6.47 billion, which has continued to underpin sentiment in the name.

The rally is being supported by the view that inpatient rehabilitation volumes remain resilient and that the company can sustain margins despite labor and operating-cost pressures that have weighed on many healthcare providers. Bulls also point to the company’s track record of using "same-store" metrics and operational initiatives to drive performance across its hospital base, which can translate into steady cash generation and room for continued investment in capacity.

The next major catalyst is the company’s upcoming quarterly reporting window (with market calendars projecting late April 2026 timing), when investors will look for confirmation that 2026 guidance remains intact or is trending higher. Key swing factors include staffing costs, case-mix and admissions growth, and any changes in reimbursement dynamics that could impact profitability for inpatient rehabilitation facilities.